An Industry Perspective on the use of Forced Degradation Studies to Assess Comparability of Biopharmaceuticals
- DOI
- 10.1016/j.xphs.2023.12.011
- Published
- 2024-03
- Container
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.xphs.2023.12.011,
title = {An Industry Perspective on the use of Forced Degradation Studies to Assess Comparability of Biopharmaceuticals},
author = {John M. Campbell and Stefano Colombo and Jamie L. Doyle and Dana I. Filoti and Göran Hübner and Laurent Magnenat and Ann K. Nowinski and Jorge Alex Pavon and Surinder M. Singh and Laila R. Vo and Joshua M. Woods and Elaine S.E. Stokes},
year = {2024},
journal = {Journal of Pharmaceutical Sciences},
doi = {10.1016/j.xphs.2023.12.011},
url = {https://doi.org/10.1016/j.xphs.2023.12.011}
}RIS
TY - JOUR TI - An Industry Perspective on the use of Forced Degradation Studies to Assess Comparability of Biopharmaceuticals AU - John M. Campbell AU - Stefano Colombo AU - Jamie L. Doyle AU - Dana I. Filoti AU - Göran Hübner AU - Laurent Magnenat AU - Ann K. Nowinski AU - Jorge Alex Pavon AU - Surinder M. Singh AU - Laila R. Vo AU - Joshua M. Woods AU - Elaine S.E. Stokes PY - 2024 JO - Journal of Pharmaceutical Sciences DO - 10.1016/j.xphs.2023.12.011 UR - https://doi.org/10.1016/j.xphs.2023.12.011 ER -
APA
Campbell, J. M., Colombo, S., Doyle, J. L., Filoti, D. I., Hübner, G., Magnenat, L., Nowinski, A. K., Pavon, J. A., Singh, S. M., Vo, L. R., Woods, J. M., & Stokes, E. S. (2024). An Industry Perspective on the use of Forced Degradation Studies to Assess Comparability of Biopharmaceuticals. Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.xphs.2023.12.011
Source records
- crossref · retrieved 2026-09-26T08:03:39.657Z